Pharmafile Logo
Pharmafocus logo
Advanced Search

hta

Showing 15 posts of 16 posts found.

EMA image

EMA looks to sharpen HTA data output

November 20, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, NICE, hta, transparency

The European Medicines Agency (EMA) has deepened its partnership with the European network for Health Technology Assessment (EUnetHTA) as it …

News
EMA image

EU orphan designations rise

February 19, 2013
Research and Development, Sales and Marketing COMP, EMA, Orphan, hta

The number of orphan drug designations in the EU is set to rise to record levels this year, according to …

News
ABPI image

ABPI slams NICE International

August 20, 2012
Sales and Marketing ABPI, NICE, NICE International, Romania, hta

The ABPI has expressed concerns over the remit of NICE International and its affect on global markets. NICE International is …

News
Avastin packs

NICE no for Avastin in breast cancer

December 8, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, breast cancer, health technology assessment, hta

NICE has refused to back Roche’s Avastin for use in breast cancer patients citing the blockbuster drug’s high cost and …

News

Change is needed, concedes NICE chief, but defends record

November 30, 2010
Sales and Marketing Andrew Dillon, NHS reform, NICE, cost-effectiveness, health technology assessment, hta, value-based pricing

The chief executive of NICE acknowledges changes are needed in how drugs are assessed in the UK – including more …

Feature

Irish cost-effectiveness guidelines published

November 15, 2010
Sales and Marketing Dr Mairin Ryan, Economic Evaluation of Health Technologies, HIQA, Health Information and Quality Authority, IPHA, Ireland, Irish Pharmaceutical Healthcare Association, NICE, hta

The Irish government has published new health technology assessment guidelines to help decision-makers estimate the cost-effectiveness of medical treatments. The …

News

NICE limits access to cancer drugs, study confirms

November 10, 2010
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Cancer Drugs Fund, IPSOR, Maximilian Lebmeier, NICE, hta

NICE became more restrictive in its assessment of new cancer drugs between 2007 and 2009, a new report suggests. The …

News

Pharma engages HTA bodies in early-stage drug discussions

October 27, 2010
Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, EMA, European Medicines Agency, GlaxoSmithKline, Johnson & Johnson, health technology assessment, hta

Three pharma companies are taking part in a new pilot to harmonise European standards in health technology assessment (HTA). AstraZeneca, …

News
European flags

European call for greater HTA co-operation

July 9, 2010
Sales and Marketing hta

The European Commissioner who oversees the pharma sector has called for greater co-operation on health technology assessment. John Dalli, the …

News

Europe must move on from ‘simplistic’ pricing

June 22, 2010
Research and Development Europe, hta, pricing, pricing & Reimbursement

GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …

News

Implementing value-based pricing in the UK

June 14, 2010
Sales and Marketing hta, pricing, value

The UK has a strong history of innovation in medicines and it is vital to the economy that this continues …

Feature

NICE warns industry on cost-effectiveness

February 9, 2010
Sales and Marketing BMS, Janssen, NICE, Novartis, hta

NICE has turned down three drugs on cost grounds and has urged the pharma industry to do more to help …

News

Promising new drugs could bypass UK approval process

December 23, 2009
Sales and Marketing MHRA, MISG, hta, market access

UK patients could next year be given access to drugs that are still in the later stages of clinical development, …

News

EU should require all trials to be registered, says IQWiG

December 1, 2009
Sales and Marketing Germany, IQWIG, health economics, hta

 Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has said that registration and publication of all clinical trials …

News

Kennedy calls for overhaul of NICE processes

July 23, 2009
Research and Development, Sales and Marketing NICE, hta

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025